推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinoma in Situ to Invasive Carcinoma

F Ayala de la Peña, K Kanasaki, M Kanasaki… - Journal of Biological …, 2011 - ASBMB
Activation of oncogenes or inactivation of tumor suppressors in urothelium is considered critical
for development of urothelial cancer. Here we report cloning of the urothelium-specific promoter
uroplakin-II (UPK II) and generation of transgenic mice in which expression of SV40 large ...
Related articles - All 3 versions

The Clinical Impact of the Classification of Carcinoma In Situ on Tumor Recurrence and their Clinical Course in Patients with Bladder Tumor

N Hayakawa, E Kikuchi, S Mikami… - Japanese Journal of …, 2011 - FPCR
Results The multivariate analysis determined that the secondary carcinoma in situ and the absence
of bacillus Calmette–Guérin therapy were the independent unfavorable risk factors for tumor
recurrence. The 5-year recurrence-free survival rates on primary, concurrent and ...
Related articles - All 3 versions

Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery

P Nuhn, PJ Bastian, G Novara… - Urologia …, 2011 - content.karger.com
... 3. Utz DC, Hanash KA, Farrow GM: The plight of the patient with carcinoma in situ of the bladder. ...
9. Solsona E, Iborra I, Ricos JV, Dumont R, Casanova JL, Calabuig C: Upper urinary tract
involvement in patients with bladder carcinoma in situ (Tis): its impact on management. ...
Related articles - All 2 versions

Flat urothelial carcinoma in situ of the bladder with glandular differentiation

A Lopez-Beltran, RE Jimenez, R Montironi… - Human Pathology, 2011 - Elsevier
We present the clinicopathologic and immunonohistochemical features of 25 cases of flat urothelial
carcinoma in situ with glandular differentiation. Previously, cases on this category have been
reported as in situ adenocarcinoma (a term not currently preferred). Fourteen of 25 cases ...
Related articles - All 3 versions

… with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an …

WL Ooi, M Stockler… - European urology, 2011 - ncbi.nlm.nih.gov
Re: Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential Intravesical Chemoimmunotherapy
with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients
with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451